Rates of colorectal cancer screening via CT colonography are higher when patients have health insurance policies that cover the screening.
Patients are more likely to undergo CT colonography for colorectal cancer (CRC) screening if their insurance policies cover the testing, according to a study published in Radiology.
Researchers from the University of Wisconsin-Madison School of Medicine and Public Health, performed a retrospective cohort study to compare overall CRC screening rates for patients who were eligible and due for CRC screening and who were with and without insurance coverage for CT colonography for CRC screening. “CT colonography is a newer technology that can detect both pre-cancer and cancer, but because it’s relatively new it isn’t widely covered by insurance and isn’t covered by Medicare,” lead author Maureen A. Smith, MD, PhD, MPH, said in a release.[[{"type":"media","view_mode":"media_crop","fid":"61761","attributes":{"alt":"Maureen A. Smith, MD, PhD, MPH","class":"media-image media-image-right","id":"media_crop_4296953263489","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"7814","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"float: right;","title":"Maureen A. Smith, MD, PhD, MPH","typeof":"foaf:Image"}}]]
The researchers evaluated data from 33,177 patients, aged 64 or younger, who were eligible and due for CRC screening. The results showed that after adjustment, those patients whose insurance policies covered CT colonography who were due for CRC screening had a 48% higher likelihood of undergoing screening by any method, compared with those who did not have similar insurance coverage. In addition, the patients with CT colonography coverage had a greater likelihood of being screened with CT colonography and with colonoscopy, but not with fecal occult blood test than those without such insurance coverage.
“Our study suggests that when people are offered a greater choice of screening tests for colorectal cancer, including CT colonography, they are more likely to complete screening to prevent colorectal cancer,” Smith said in the release. “Policymakers should consider additional options for screening and prevention of colorectal cancer. CT colonography is potentially a powerful option, because there are people who will prefer it.”
Study with CT Data Suggests Women with PE Have More Than Triple the One-Year Mortality Rate than Men
April 3rd 2025After a multivariable assessment including age and comorbidities, women with pulmonary embolism (PE) had a 48 percent higher risk of one-year mortality than men with PE, according to a new study involving over 33,000 patients.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Predicting Diabetes on CT Scans: What New Research Reveals with Pancreatic Imaging Biomarkers
March 25th 2025Attenuation-based biomarkers on computed tomography (CT) scans demonstrated a 93 percent interclass correlation coefficient (ICC) agreement across three pancreatic segmentation algorithms for predicting diabetes, according to a study involving over 9,700 patients.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.